CorMedix Inc.·4

Dec 17, 5:09 PM ET

Khan Mehmood 4

4 · CorMedix Inc. · Filed Dec 17, 2019

Insider Transaction Report

Form 4
Period: 2019-12-13
Khan Mehmood
Director
Transactions
  • Purchase

    Common Stock

    2019-12-13$6.58/sh+17,000$111,925133,017 total
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.25Exp: 2027-06-25Common Stock (15,000 underlying)
    15,000
Footnotes (4)
  • [F1]Reflects the weighted average price of purchases made on the NYSE American on December 13, 2019. The shares were purchased in multiple transactions at prices ranging from $6.47 to $6.75, inclusive. The reporting person undertakes to provide to CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
  • [F2]These options were granted on 01/10/2019. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F3]These options were granted on 02/16/2018. These options are fully vested.
  • [F4]These options were granted on 06/25/2017. These options are fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    PRIMARY DOCUMENT